ArticleBritish journal of cancer2013

A phase I study of the combination of ro4929097 and cediranib in patients with advanced solid tumours (PJC-004/NCI 8503).

S Sahebjam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.